KAVASAFE
Live / Registered — Registered (as of 27 Jan 2026)
What this means for you
Registered since 27 Jan 2026. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98897259
- Registration number
- 8120831
- Mark type
- Stylized text
- Filed
- 11 Dec 2024
- Published for opposition
- 08 Apr 2025
- Registered
- 27 Jan 2026
Goods and services
- Class 005 — Pharmaceuticals: Dietary supplements; nutritional supplements; dietary supplements and nutritional supplements containing kava; pharmaceutical preparation, namely kava being a dietary ingredient manufactured by a proprietary process that results in kava being absorbed in the intestinal tract in a time-dependent manner; pharmaceutical feature in the nature of a sustained-release delivery ingredient in the nature of dietary supplements and nutritional supplements, made in significant part from kava, sold as an integral component of dietary supplements and nutritional supplements for alleviating anxiousness, improving mood, relieving tension, improving sleep, and supporting cognitive function.
Owner
- Tesseract Medical Research, LLC, Laguna Hills, CA, US
- Tesseract Medical Research, LLC, Laguna Hills, CA, US
- Tesseract Medical Research, LLC, Laguna Hills, CA, US
Prosecution history
- 27 Jan 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 27 Jan 2026 — REGISTERED-PRINCIPAL REGISTER
- 07 Jan 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 07 Jan 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 05 Jan 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 30 Jun 2025 — USE AMENDMENT FILED
- 05 Jan 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 30 Jun 2025 — TEAS STATEMENT OF USE RECEIVED
- 03 Jun 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 08 Apr 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 08 Apr 2025 — PUBLISHED FOR OPPOSITION
- 02 Apr 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 12 Mar 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 04 Mar 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 04 Mar 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE